Acrux Limited (AU:ACR) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Acrux Limited is set to host an Investor Webinar on December 17 to update shareholders and investors on the commercialisation of its Nitroglycerin 0.4% ointment. Acrux, a specialty pharma company, has a strong track record in developing topical pharmaceutical products and is seeking to expand its market presence through partnerships and new product developments.
For further insights into AU:ACR stock, check out TipRanks’ Stock Analysis page.
